Vaccine Therapy in Treating Patients With Stage IV Head and Neck Cancer

Completed · Phase 1

Conditions studied: Head and Neck Cancer, Metastatic Cancer

In brief

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients who have stage IV head and neck cancer.

Key facts

Study ID

NCT00021424

Run by

National Institute on Deafness and Other Communication Disorders (NIDCD)

Starts

2001-06-01

Last updated by the study team

2015-04-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Warren Grant Magnuson Clinical Center — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.